Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies
2013 · Journal of Psychopharmacology · 68 citations
https://doi.org/10.1177/0269881113480990
G
Graeme Archer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
647
Citations
10
h-index
11
i10-index
Graeme Archer is an academic researcher from GlaxoSmithKline (Netherlands). The author has contributed to research in topics: Statistical Methods in Clinical Trials & Advanced Causal Inference Techniques & Advanced Image Processing Techniques. The author has an h-index of 10, co-authored 19 publications.
Papers by this author
worksEfficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials
2011 · Journal of Psychopharmacology · 24 citations
https://doi.org/10.1177/0269881111424931
Predicting the COVID-19 Pandemic Impact on Clinical Trial Recruitment
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.16941089
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat